We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trial Concerning the Frequency of Parastomal Hernia With or Without a Mesh (STOMAMESH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00917995
Recruitment Status : Completed
First Posted : June 11, 2009
Last Update Posted : October 16, 2015
Sponsor:
Information provided by (Responsible Party):
Pia Nasvall, Norrbottens Lans Landsting

Brief Summary:

Specific aim:

To compare patients with colostomies with or without mesh at the primary operation. Primary endpoint is the incidence of parastomal hernia requiring surgery.

All patients at participating centers scheduled for permanent colostomy, after signing informed consent and meeting inclusion criteria, will be randomised to formation of a stoma with or without mesh.

If the inclusion criteria is fulfilled and informed consent is signed, the patient is randomised preoperatively.


Condition or disease Intervention/treatment Phase
Parastomal Hernia Device: Polypropylene Mesh, density 25-40g/square meter Phase 2 Phase 3

Detailed Description:

Parastomal hernia is a relatively common and troublesome complication in patients with a stoma. The exact incidence is not known and depending on definitions and if a bulging is a hernia or not, as well as when after the operation the examination is performed, the incidence varies between 0-48%. A parastomal hernia may give the patient difficulties with appliance and leakage. From an economical point of view a stoma that requires special kinds of appliances is expensive. Theoretically, strengthening of the abdominal wall with a mesh at the the primary operation would reduce the risk for parastomal hernia. Recently presented data suggest that a mesh at the primary operation really does reduce the risk to develop a parastomal hernia. No negative side effects with the use of a mesh have been reported in these studies. All earlier studies have involved relatively small numbers of patients and short times of observation, and therefore under-dimensioned concerning potential negative late side-effects. Complications seen in other studies where mesh has been used in surgery of the bowel include fistulas and infections among others. To understand if mesh at the primary operation, in a safe way, reduces the risk for developing parastomal hernia compared to conventional surgery, is important to perform this new prospective randomised multicenter trial.

Specific aim:

To compare patients with colostomies with or without mesh at the primary operation. Primary endpoint is the incidence of parastomal hernia requiring surgery.

All patients at participating centers scheduled for permanent colostomy, after signing informed consent and meeting inclusion criteria, will be randomised to formation of a stoma with or without mesh.

If the inclusion criteria is fulfilled and informed consent is signed, the patient is randomised preoperatively.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 241 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Prevention
Official Title: STOMAMESH Prospective Randomised Multicenter Trial Concerning the Frequency of Parastomal Hernia With or Without a Mesh
Study Start Date : January 2008
Actual Primary Completion Date : September 2015
Actual Study Completion Date : September 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Hernia

Arm Intervention/treatment
Experimental: Colostomy with a prophylactic mesh Device: Polypropylene Mesh, density 25-40g/square meter
colostomy with a prophylactic hernia mesh

No Intervention: Colostomy without a prophylactic mesh



Primary Outcome Measures :
  1. The number of parastomal hernias in the two groups at 12 and 36 months postoperatively [ Time Frame: At 12 and 36 months postoperatively ]

Secondary Outcome Measures :
  1. Quality of life related to health [ Time Frame: At 12 and 36 months postoperatively ]
  2. The health care systems total cost related to the stoma [ Time Frame: At 12 and 36 months postoperatively ]
  3. Rate of infections 30 days postoperatively [ Time Frame: At 30 days postoperatively ]
  4. Late complication related to the mesh leading to surgery [ Time Frame: At 12 and 36 months postoperatively ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient is scheduled for permanent colostomy elective or acute operation. The optimal site for stoma is marked preoperatively.
  • No previous stoma.
  • Over the age of 18.
  • Informed consent signed by the patient.

Exclusion Criteria:

  • Expected lifetime less then 3 years.
  • Fecal peritonitis (perforated bowel with free intestinal content in the peritoneal cavity).
  • Previous stoma.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00917995


Locations
Layout table for location information
Sweden
Sunderby Hospital
Lulea, Sweden, 97180
Sponsors and Collaborators
Norrbottens Lans Landsting
Investigators
Layout table for investigator information
Study Chair: Michael Dahlberg, MD PhD Dept of Surgery Sunderby Hospital, Luela, Sweden
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Pia Nasvall, MD, PhD, Norrbottens Lans Landsting
ClinicalTrials.gov Identifier: NCT00917995    
Other Study ID Numbers: 07-081M
First Posted: June 11, 2009    Key Record Dates
Last Update Posted: October 16, 2015
Last Verified: October 2015
Keywords provided by Pia Nasvall, Norrbottens Lans Landsting:
parastomal hernia
prophylactic mesh
colostomy
hernia
Additional relevant MeSH terms:
Layout table for MeSH terms
Hernia
Pathological Conditions, Anatomical